The efficacy and safety of pyrotinib in treating HER2-positive metastatic breast cancer patients: a multicenter study

INTRODUCTION: To evaluate the clinical outcomes and safety profile of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients. MATERIAL AND METHODS: This is a multicenter retrospective study. Eligible enrolled HER2-positive MBC patients who received pyrotinib-containing regimens were incl...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Min Gao, Yuhui Li, Qingfen Dong, Fang Chen, Chao Fu, Shuaishuai Liu, Shuai Liu, Xiao Ju, Xin Zheng, Jie Lu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Via Medica 2026-07-01
סדרה:	Oncology in Clinical Practice
נושאים:	efficacy HER2 breast cancer brain metastasis pyrotinib safety
גישה מקוונת:	https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/105828
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!